Skip to Content

RDY 572 (Fexofenadine and Pseudoephedrine Extended Release 180 mg / 240 mg)

Pill with imprint RDY 572 is White, Capsule-shape and has been identified as Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release 180 mg / 240 mg. It is supplied by Dr. Reddy’s Laboratories Limited.

Fexofenadine/pseudoephedrine is used in the treatment of allergic rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Fexofenadine/pseudoephedrine 180 mg / 240 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for RDY 572

Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release

RDY 572
180 mg / 240 mg
Rx and/or OTC
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy’s Laboratories Limited
Inactive Ingredients:
acetyltributyl citrate
croscarmellose sodium
silicon dioxide colloidal
microcrystalline cellulose
polyethylene glycol
sodium stearyl fumarate
magnesium silicate
titanium dioxide
hydrogenated cottonseed oil
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.